Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs Clinical research trials and A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs. A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs clinical trial. Human subjects often get the best healthcare possible for their A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.

Home > "A" Clinical Trials Conditions > A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs

A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs



A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs

For Condition: HIV Infections
Status: No longer recruiting
Sponsor(s): Bristol-Myers Squibb ,
Synopsis: To make stavudine (d4T) available to patients with advanced HIV disease for whom no alternative antiretroviral is satisfactory. To study the safety and efficacy of two dose levels in a twice-daily regimen.
Details:
Eligibility:
Study Type:  Interventional, Treatment, Double-Blind, Safety Study
Minimum Age/Maximum Age: 13 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - HIV positivity with CD4 count < 300 cells/mm3. - Intolerance to or failure on approved antiretroviral therapy. - Ability to provide informed consent (of parent or guardian if appropriate). NOTE: - Incarcerated persons may be eligible to participate. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Grade 2 or worse disease-related peripheral neuropathy. - Unresolved drug-related peripheral neuropathy of any severity that is attributable to other nucleoside analogs (AZT, ddC, ddI). - Malignancy likely to require systemic chemotherapy with myelosuppressive or neurotoxic drugs in the first 3 months of stavudine treatment. - Pregnancy (physicians of pregnant patients may contact Bristol-Myers to determine eligibility for stavudine therapy in another protocol). Strongly discouraged: - AZT, ddI, ddC, and other antiretroviral agents.
Total Enrollment: 

Location and Contact Information:

Bristol - Myers Squibb Co
Princeton,  New Jersey,  085434500
United States
 


Additional Information:
Study ID Numbers:  116B;  AI455-900
Study Start Date: 
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002308

Other Hiv Infections Studies:
1. Cause of Focal Segmental Glomerulosclerosis

2. Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma

3. Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders

4. A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection

5. Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients

Related Studies:

Other HIV Infections Clinical Trials
Other New Jersey Clinical Trials
Other Princeton Clinical Trials

A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success with Other Anti-HIV Drugs
Modify your Search

  Other HIV Infections Clinical Trials
  Other New Jersey Clinical Trials
  Other Princeton Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103